Elanco Animal Health ELAN
NYSE ELAN
$23.60 -0.90 (-3.65%)
At close: Aug 20, 2026 · 12:58 PM UTC

Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2026)

Elanco Animal Health (ELAN) posted Other Accumulated Expenses of $817.0 million for Q1 2026, up 10.55% sequentially from $739.0 million in Q4 2025, and up 41.84% YoY from $576.0 million in Q1 2025.

Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

Elanco Animal Health has reported Other Accumulated Expenses for 10 years, with the latest figure at $817.0 million in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 41.84% year-over-year to $817.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $817.0 million (up 41.84% YoY) and the FY2025 annual result came in at $739.0 million, up 58.58% from the prior year.
  • Other Accumulated Expenses grew to $817.0 million in Q1 2026 per ELAN's latest filing, from $739.0 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $817.0 million in Q1 2026 and troughed at $377.0 million in Q1 2023.
  • A 5-year average of $551.4 million and a median of $559.0 million in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses declined 23.56% in 2022, then surged 58.58% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $454.0 million in 2022, then declined by 9.91% to $409.0 million in 2023, then climbed by 13.94% to $466.0 million in 2024, then soared by 58.58% to $739.0 million in 2025, then gained by 10.55% to $817.0 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $817.0 million, $739.0 million, and $665.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 902.00 Mn
Mar 31, 2026 817.00 Mn
Dec 31, 2025 739.00 Mn
Sep 30, 2025 665.00 Mn
Jun 30, 2025 596.00 Mn
Mar 31, 2025 576.00 Mn
Dec 31, 2024 466.00 Mn
Sep 30, 2024 685.00 Mn
Jun 30, 2024 510.00 Mn
Mar 31, 2024 574.00 Mn
Dec 31, 2023 409.00 Mn
Sep 30, 2023 574.00 Mn
Jun 30, 2023 559.00 Mn
Mar 31, 2023 377.00 Mn
Dec 31, 2022 454.00 Mn
Sep 30, 2022 435.00 Mn
Jun 30, 2022 499.00 Mn
Mar 31, 2022 438.00 Mn
Dec 31, 2021 433.00 Mn
Sep 30, 2021 390.00 Mn